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ABSTRACT
Background: In 1996 the Washington Panel controversially recommended
valuing productivity costs (PC) in terms of quality-adjusted life years. The
Panel’s assumption that respondents in health state valuation (HSV) exer-
cises take income losses into account could not be countered since there
was no evidence regarding what people consider in HSV exercises. If they
do consider income losses and if this changes HSVs, then all economic
evaluations that have included PC in the numerator may have double-
counted these costs. Alternatively, if respondents do not consider income
losses then all past economic evaluations that have not included PC in the
numerator have failed to account for sizeable societal costs.
Objectives: Through a review we aim to recapture the debate surrounding
the appropriate method for including PC in health economic evaluations,
to identify empirical evidence addressing the assumptions of the Panel, and
recommend a future research agenda.
Methods: Through a review we identify, outline, and critically appraise
the existing empirical studies that attempt to address whether respondents
include income effects in HSV exercises.
Results and conclusion: Seven empirical studies were identiﬁed. Overall, it
seems that not explicitly mentioning the inclusion of income will induce a
minority of respondents to include these effects and this appears not to
inﬂuence results. More empirical work is needed, using generic instru-
ments, larger samples, and using the interview method of administration.
Keywords: health state valuation, income effects, productivity costs,
quality-adjusted life years.
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Economic evaluations increasingly inﬂuence decisions on the
allocation of scarce resources within the health-care sector. The
general idea behind these economic evaluations is that health-
care programs should offer sufﬁcient value for money in order to
warrant their funding. In order to properly determine the value
for money of health-care programs, from the societal point of
view, it is pivotal that all relevant costs and effects are included in
the evaluation in an appropriate way.
One area of particular debate is that of productivity costs,
which have been deﬁned as “costs associated with production
loss and replacement costs due to illness, disability and death of
productive persons, both paid and unpaid” [1]. In a Cost-
effectiveness Analysis, changes in productivity costs were typi-
cally valued in monetary terms in the numerator of the cost-
effectiveness ratio (C/E) through either the human capital (HC)
or friction cost (FC) method. However, in 1996, the Washington
Panel argued that productivity costs are, and indeed should be,
included in the denominator of the C/E ratio [2]. They are
included as health effects according to the Panel, because in
health state valuation (HSV) exercises respondents are assumed
to consider the effect that a health state will have on income (and
these income losses act as a proxy for productivity costs) even
when the valuation method is silent regarding income. To include
productivity costs in the numerator of the C/E ratio in monetary
terms, as commonly done, would result in double-counting these
costs, which should obviously be avoided. Alternatively, if
respondents do not (consistently) consider income effects in
HSVs or if the inﬂuence of such considerations on the valuations
is negligible, then economic evaluations using the Washington
Panel Approach have excluded real and sizeable societal
costs. Therefore, to ensure a good distinction between costs
and effects in health economic evaluations, in order to avoid
double-counting and ensure the inclusion of real societal costs,
it is pivotal to determine what respondents consider in HSV
exercises.
By now, empirical evidence on this issue has become avail-
able. Studies on whether respondents consider income in HSVs
when these are silent on this matter have been published. Some of
these studies also consider the inﬂuence of providing respondents
with explicit information on income losses associated with a
given health state or with explicit instructions on the inclusion or
exclusion of possible income changes. These studies thus all
directly address the issue of inclusion of income losses in HSVs,
which is central in the recommendations made by the Washing-
ton Panel.
In this review article we do not add to the existing empirical
work. We ﬁrst outline the different approaches to valuing pro-
ductivity costs in economic evaluations. We then present the
ﬁndings of existing empirical studies that have attempted to
determine whether or not respondents in HSV exercises consider
income effects. In doing so, we will consider the implications of
the results for the inclusion of productivity costs and the elicita-
tion of HSVs in economic evaluation. Moreover, we will expose
unresolved issues and hence research priorities for the future. In
contrast to previous studies [3–5], this article covers the recent
empirical developments on the inclusion of income changes in
HSVs.
Background
The inclusion of productivity costs in economic evaluations has
been and still is controversial. When a broad societal perspec-
tive is adopted, as is often recommended [2,6], and which
follows logically from the welfare theoretical roots of economic
evaluations [7], all costs and effects should be considered in an
analysis. In this article we do not address the normative question
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of whether productivity costs should be included in economic
evaluations. Rather, we simply address the issue of how to
include them in an appropriate way, focusing on the question of
whether productivity costs (or rather income changes) are, or
can, be included in HSVs.
Health economic evaluations normally take the speciﬁc form
of cost-effectiveness analyses or, preferably, cost-utility analyses.
The latter type of analysis uses the Quality-adjusted Life Year, or
QALY gained [8] as a measure of health improvements. Impor-
tantly, these analyses, unlike traditional cost-beneﬁt analyses,
require the determination of what is counted as a health effect
(nonmonetarily) and what as costs. Moreover, as in any analysis,
double-counting of impacts needs to be avoided and an adequate
measurement and valuation method needs to be applied. In that
context, it was (and largely still is) common practice and consid-
ered most appropriate to incorporate productivity costs in the
analysis as costs in the numerator of the cost-utility ratio.
However, in 1996 the Washington Panel controversially recom-
mended the inclusion of productivity costs almost entirely
through HSVs and therefore in terms of quality of life (QoL) in
the denominator of the C/E ratio [2].
Valuing Productivity Costs in Monetary Terms—The
Human Capital (HC) and Friction Cost (FC) Methods
Two main methods for valuing productivity costs existed before
the US Panel proposed their “third way.” The ﬁrst is the HC
approach [9,10]. Under this approach lost production (often
related to paid work) as a result of morbidity or mortality is
valued by measuring time lost from work and multiplying this
with the gross wage of the involved individual. Economic theory
suggests that under certain conditions, at the margin, gross
wages equal the productive value of individuals, so that this
multiplication should yield a good estimate of the value of lost
production. The relevant period of time over which costs (or
savings) are measured is, unless restricted by the time horizon of
the analysis, the total period of time in which a person is
(un)able to be productive compared to the alternative scenario.
In the case of disability or premature death this can obviously
amount to many years i.e., until the retirement age would have
been reached. If a 45-year-old individual earning £30,000 per
year became unable to work due to permanent disability, the
estimated value of productivity losses under the HC method
(assuming a retirement age of 65) would be: 20 ¥ £30,000, i.e.,
£600,000. For examples of economic evaluations that have used
the HC approach, see Beutels et al. [11], Ford et al. [12], and
Kobelt et al. [13].
The neoclassical theory on which the HC approach is based
assumes that all markets clear. However, in reality the existence
of involuntary unemployment means that when someone is
forced to leave the workforce due to illness they can be replaced
by a previously unemployed person. To be able to explicitly value
productivity costs from a societal perspective and in relation to
economic circumstances, the FC method was developed [14–16].
Under this approach the period in which productivity costs occur
is limited to the time it takes to replace a worker. The FC method
argues that, from a societal point of view, there are no production
losses in the long run, since the production loss in the ill, dis-
abled, or deceased worker is cancelled out by a production gain
in the new, formerly unemployed, worker. Estimates of the value
of productivity change according to the FC method do include
some additional costs such as the resource cost associated with
recruiting and training replacement workers (e.g., advertising the
job vacancy). Unsurprisingly, the estimates of the FC and HC
methods do not differ signiﬁcantly for short-term absence [17].
However, in the case of mortality and long term morbidity these
differences are substantial. The estimated value of productivity
losses for society in the case of an individual permanently dis-
abled, mentioned above, would be considerably lower for the FC
method than for the HC method. If it took 1 year to ﬁnd a
replacement worker, and there were advertising and training
costs of £10,000, the total cost would be £40,000 (vs. £600,000
in the HC approach). For examples of economic evaluations that
have used the FC approach, see Glick et al. [18], Van Enckevort
et al. [19], and Nord et al. [20]. The criticism of the FC method
mainly relates to the valuation of leisure time; see Johannesson
and Karlson [21], Liljas [22], Koopmanschap et al. [23], Johan-
nesson [24], and Brouwer et al. [25].
Valuing Productivity Costs as Part of the Health Effects:
The Washington Panel Approach
The Panel asserts that in valuing imperfect health states, respon-
dents will consider their productivity and income level. In other
words, the Panel assumes that when answering HSV questions
(for example, the Time Trade-off [TTO] [26]) respondents will
take account of the effect a potential health state will have not
only on their ability to work as a form of role functioning [25]
but also on their income. The Panel thus proposes that produc-
tivity costs can, should, and, in fact, already are included in
utility scores for imperfect health states. Most HSV instruments
are silent on the topic of income changes (with the exception of
the Health Utilities Index [HUI] instruments), but the Panel
argues this is sufﬁcient for inclusion of these effects. It is worth
noting that the Panel does not deny the possibility of replacement
of ill workers. It recommends replacement costs be calculated
and included in the numerator. For an example of an economic
evaluation that has used the Washington Panel Approach, see
Wang et al. [27].
If we assume that respondents in health states valuations on
average lower their valuation of some health state by 0.05 (on a
scale with 1 for full health and 0 for dead) and the permanently
disabled individual lives for another 20 years to become 65, then
one additional QALY is being lost (i.e., 20 ¥ 0.05). A treatment
that will enable him to return to work will thus gain one addi-
tional QALY relative to QALYs gained without income being
considered.
The Washington Panel Approach has received considerable
criticism. An individual’s income may be a poor proxy for his
productivity and hence the stable relationship implicitly assumed
by the Panel may not exist [1,25,28]. Productivity changes may
not cause income changes proportional to productivity changes if
social beneﬁts (or payments from private insurance) are received
to compensate for the reduction in labor income. Thus, the
impact of productivity on income may ﬂuctuate with age (e.g.,
after retirement, income is likely to be independent of produc-
tivity). It may also be difﬁcult for respondents to accurately
predict how (generic) health states affect productivity and, con-
sequently, income. Moreover, illness may cause productivity
losses without absence (i.e., reduced productivity at work or
“presenteeism”). Brouwer et al. [1] argued that adoption of the
Washington Panel Approach would lead to an omission of these
costs since these productivity losses often do not translate into
income losses. Furthermore, Meltzer and Johannesson [29] note
that if people (are to) incorporate personal ﬁnancial conse-
quences such as income losses into QALY weights, they will
presumably also incorporate other consequences such as out-of-
pocket medical expenses related to, for example, pharmaceuti-
cals or hospitalization (whenever relevant) and the value of time
forgone participating in health interventions. However, since the
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Panel advises including both of these factors in measures of costs,
this would then result in double-counting. Further criticism of
the Washington Panel Approach, such as the failure to take
account of the income gain achieved by the previously unem-
ployed member of society, can be found in Brouwer et al. [1]. In
general, it seems likely that respondents in HSV exercises take an
individual rather than a societal perspective, so that costs and
gains in others (employers, replacement workers, etc) will remain
unvalued.
In or Out? Empirical Studies So Far
To our knowledge seven empirical studies on this issue have been
published so far [30–36]. To conﬁrm there were no other studies
that we were unaware of we performed a Medline search (via
Pubmed). We used a title and abstract search with the following
terms: “health state valuation OR TTO OR SG OR VAS OR
quality of life AND (lost income OR income effects OR income
loss OR productivity costs) AND consider OR included OR
inclusion OR instruction OR double-counting.” This gave 297
results. The inclusion criteria were any study that had empirically
tested the inclusion of income in HSVs. All but one of the studies
that we were aware of appeared in the search. The one that did
not appear [30] is only available as an abstract, and hence does
not appear in Medline. We did not ﬁnd any other empirical
studies. Table 1 provides an overview of the key ﬁndings and
characteristics of the seven empirical studies.
The earliest study was performed in the United States by
Meltzer and colleagues [30], asking 402 subjects to value back
pain and 429 to value blindness using the TTO method.
Respondents were randomly assigned one of three different ver-
sions of TTO: in version 0, no guidance was given about ﬁnan-
cial consequences; in version 1, respondents were told that 60%
of their current income would be provided as disability pay-
ments; and in version 2, they were told that there would be no
disability payments. When questioned after the TTO, of respon-
dents presented with version 0 of the questionnaire, less than
15% indicated they had considered the ﬁnancial consequences
of either health state valued. This means that what has been
labeled as “spontaneous inclusion” of income when the TTO
question is silent on the issue is relatively uncommon, unlike the
suggestion of the Panel. Even for version 2, this ﬁgure was still
less than 25%.
One would expect version 2 to elicit the lowest value, while
making predictions for versions 0 and 1 is more difﬁcult.
However, given that so few people include income effects, even in
version 2, any differences between the versions are likely to be
small. The mean TTO scores for blindness were 4.95, 4.83, and
4.84 for versions 0, 1, and 2 respectively (insigniﬁcant). The
mean TTO scores for back pain were 5.09, 5.78, and 4.25 for
versions 0, 1, and 2, respectively. When comparing with version
0, the results for back pain were signiﬁcantly different at the 10%
and 5% signiﬁcance levels for versions 1 and 2, respectively.
Unfortunately the differences in results between those that did
and did not consider income effects are not presented. The sig-
niﬁcant results for back pain conﬁrm that version 2 elicits the
lowest utility value. However, the relatively high value for
version 1 (back pain) is somewhat surprising, which demon-
strates the need for further exploration of why subjects
responded to the HSV exercises in the way that they did.
The main conclusion of the authors is that the “economic
costs of illness are unlikely to be reﬂected in QoL questions, so
these need to be counted separately” (p. 517). Furthermore they
argue that “it may be best to instruct people to ignore the
economic consequences of illness in answering QoL questions”
(p. 517). Explicit instructions were proposed as a means of
“breaking the silence” in order to ensure consistency between
respondents regarding what they consider in conventional HSVs.
This study was only published as an abstract, in which the
speciﬁc survey method is not mentioned, the exact scale of the
TTO values is not explained, and no background characteristics
of the sample are given (age and occupation would be particu-
larly useful in interpreting income effects).
A second study was performed by Sendi and Brouwer [31],
who presented 20 health professionals (5 medical doctors, 2
medical researchers, and 13 nurses), in Switzerland, with a ques-
tionnaire that described the health status of a 30-year-old male
patient suffering from multiple sclerosis. They were asked to rate
the health state on a visual analogue scale (VAS) ranging from 0
(worst possible health) to 100 (best possible health). The ques-
tionnaire was silent on the condition’s effect on income (as well
as on leisure). After answering the VAS question (the “ex ante
valuation”), respondents were asked whether the impact ill
health may have on income was included in their valuation. If
respondents gave a negative response, they were explicitly asked
to consider income (and leisure) effects in the valuation of
the health state in an identical second VAS question (“ex post
valuation”), but the actual magnitude of income loss was not
speciﬁed.
The results show that 60% of respondents did not consider
the effects of ill-health on income in the ﬁrst instance (i.e., when
the measure was silent), and, as expected, those who did not
consider income had a signiﬁcantly higher mean VAS score com-
pared with those who did consider income (48.33 vs. 31.25),
although these groups also varied in terms of the inclusion of
leisure. The ex post valuation for those respondents who did not
include leisure and income in the ﬁrst round was signiﬁcantly
lower than their ex ante valuation, but this effect seems especially
to be driven by leisure considerations. As acknowledged by the
authors, this study has a small sample size weakening any poten-
tial conclusions. Also, in this study, background characteristics of
the sample are not provided. The study moreover used a VAS as
the valuation component. Since the aim was to ﬁnd out whether
people would include income effects in conventional valuation
exercises, the VAS was anchored to best and worst imaginable
health, meaning that, conceptually, only if respondents consider
income to be a part of health would they include it in valuations
on this scale.
A third study was that by Krol and colleagues [32]. They
administered HSV questionnaires, using a similar VAS scale as
Sendi and Brouwer [31] did, to 227 members of the general
population in The Netherlands. Besides looking at spontaneous
inclusion of income (and leisure), this study also addressed the
topic of the effects of explicit prior instructions regarding inclu-
sion of income effects on HSVs. The aim of the study therefore
was to test: 1) whether or not respondents spontaneously include
the effect of ill health on income (and leisure); 2) the impact on
the valuation of inclusion (or exclusion) of income effects; and 3)
the inﬂuence of explicit instruction on this matter. To test this,
three versions of the questionnaire were administered. The ﬁrst
version included no directions and those who spontaneously
included income effects were asked to revalue the state again but
excluding these effects. (Note that this is exactly opposite to the
ex post valuation in Sendi and Brouwer [31], who asked people
who did not include income in the ex ante phase, to revalue the
health states now including income. Moreover, the ex post valu-
ation now pertained to income only, not leisure). In the second
version respondents were explicitly instructed up front to incor-
porate income effects in their valuations, while in the third
version respondents on the contrary were explicitly instructed to
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assume that income would not change. Each respondent
answered all three versions. Respondents valued three health
states described by the EuroQol descriptive system (EQ-5D) [37]:
mild (21211), medium (22221), and severe (33312). The EQ-5D
has ﬁve dimensions (mobility, self-care, daily activities, pain, and
depression) and three levels in each, so it can describe a total of
243 different health states. Therefore, the mild state above has
moderate problems in the ﬁrst and third dimensions and no
problems in the other dimensions.
A total of 185 questionnaires were useful for further analysis.
The authors acknowledge that the relatively high number of
noncompleted questionnaires (18.5%) suggests that HSVs may
be difﬁcult to understand for members of the general public, and
an oral instruction may have been beneﬁcial. The average age of
the sample was 35 (SD 13), which is younger than that of the
general population, which may be important if younger people
would be less or more concerned about potential income losses
due to ill health. Moreover, 22% of the respondents did not have
paid work. This implies that these respondents do not experience
income losses in the event of illness. Furthermore, 51% of the
sample had a higher level of education (vocational colleges and
academic education), and 49% had a relatively high income
(>$1900 per month). As the authors acknowledge, such a sample
is not representative of the general public, which may lead to
biased results. For instance, one might expect more educated
respondents to give more thought to the valuation exercise and
fully consider the potential consequences of a given state, and
hence be more likely to consider income effects. On the other
hand, they might also think more about the concept of health and
purposely leave out income effects from the valuation on a VAS
measuring health. In the case of higher income respondents, these
may be more likely to exhibit noticeable income effects, since
they stand to lose more money in absolute terms due to ill health,
but on the other hand, they may normally have jobs in which at
least some forms of health problems will less quickly inﬂuence
their productivity. Therefore, making clear predictions about the
inﬂuence of these background characteristics is quite difﬁcult.
For the experiment of comparing the three versions of the
questionnaire, the biased sample should have had little effect on
the results since the groups that did and did not consider income
(both instructed and spontaneously) did not differ in this respect.
In the absence of instruction 36% of respondents included
income effects (comparable to the results of Sendi and Brouwer
[31] above), but valuations of the two groups were not signiﬁ-
cantly different (contradicting the ﬁndings of Meltzer and col-
leagues [30] and Sendi and Brouwer [31]). When those that
indicated that they had considered income effects in version 1
were asked to repeat the exercise assuming no income effects, no
signiﬁcant differences in valuations were observed in the case of
state 1. This is not surprising, given that the majority of respon-
dents did not think this state would reduce their income. In the
case of states 2 and 3, valuations did change signiﬁcantly (revised
upwards). However, over half of the respondents did not change
their valuations (which were also observed for income effects in
the study of Sendi and Brouwer [31]) and this held for all three
states. Across all respondents there were no signiﬁcant differ-
ences between valuations using version 2 or version 3, suggesting
that explicit instruction does not matter in the sense that it does
not change the overall results, and this again holds for all three
health states. Therefore, instructing respondents to either include
or exclude income effects in their HSVs in this study did not
result in a noticeable difference between the groups. This casts
serious doubts on whether the Washington Panel Approach to
valuing productivity costs is accurate. The authors acknowledge
that using VAS as a valuation technique may have driven the
results somewhat, as it may be expected to be relatively insensi-
tive to income effects when respondents do not consider this a
part of health.
Krol and colleagues [35] attempt to replicate their ﬁrst study
now using the TTO method. This method is not only better
accepted as a valuation technique for health states, but also
conceptually, it may allow respondents to more easily consider
broader consequences of illness, like income changes, in their
valuations. In this study, Krol and colleagues used the same three
versions of the questionnaire as above (no mention of income,
explicit inclusion of income effects, and explicit exclusion of
these effects), aim to test the same hypotheses and ask people to
value the same three EQ-5D health states. A total of 210
members of the general public in The Netherlands participated in
the study. For version 1, when there was no mention of income
loss, 64% of respondents spontaneously included these effects (a
much higher value than previous studies), but as with the study
by Krol and colleagues [34] there were no signiﬁcant differences
in valuations between the respondents who did and those who
did not spontaneously include income. When those that indicated
that they had included income effects in version 1 in the ex ante
valuation were asked to repeat the exercise assuming no income
effects, the ex post valuation showed no signiﬁcant differences
compared to the ex ante. Comparing responses to versions 2 and
3, the ﬁnding of Krol and colleagues [32] were conﬁrmed: that no
signiﬁcant differences between these versions occur. As with the
study by Krol and colleagues [32] the average age of the sample
was quite low (35) and a large proportion did not have paid
work (28%), but again, within the experiment these characteris-
tics cannot explain the results. The authors furthermore stress
that some results may have been insigniﬁcant due to a lack of
statistical power, owing to the relatively small convenience
sample used (although this is the second largest sample of the
studies identiﬁed). Also, the TTO questions are framed in such a
manner that may lead respondents to believe they can only make
a minimum trade of 1 year. This is likely to effect the values
obtained, especially in the case of the mildest state (21211), but
again, it is unlikely that this has had an inﬂuence on the com-
parisons made within this study.
Richardson and colleagues [34] performed a study in Austra-
lia, also using the TTO method. Individuals who had completed
TTO interviews as part of the construction of the Vision Quality
of Life Index (VisQoL) multi-attribute utility instrument [38]
were questioned about their assumptions concerning income and
the amount of thought given to income during a TTO interview.
A total of 28 different multi-attribute health states were valued.
The two hypotheses they aimed to test were: 1) when there is no
explicit statement about income in the exercise the majority of
TTO respondents will assume that in a very poor health state
their incomes will fall; and 2) TTO scores will be lower when
subjects assume that their incomes will fall. The sample consisted
of 70 visually impaired patients and 61 members of the general
population. After completion of the TTO interview an “income”
questionnaire was administered to the population group at
follow-up by post. Due to their visual impairment the question-
naire was administered to the patient group as a face-to-face
interview immediately after completion of their TTO questions.
The questionnaire ﬁrst asked respondents how much thought
they gave to income and spending, with possible answers of “no
thought,” “a little thought,” or “a lot of thought.” Second, the
respondents who had considered income and spending were
asked whether they assumed that their income would remain the
same, would be lower, or would be much lower.
The results showed that only 9.1% of the respondents gave a
lot of thought to income and spending, while 62% gave the issue
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no thought. While 38% of respondents did think about income a
little or a lot, only 26.7% of these believed their income would
fall a little or a lot, leading to a rejection of the ﬁrst hypothesis.
Ordinary least squares regression was used to test the second
hypothesis. The results suggested a strong negative relationship
between thinking a lot about income and the disutility score (i.e.,
the more the respondents thought about income the higher their
TTO value, which is counterintuitive). However, the signiﬁcance
of this result disappeared in the random effects model. Both
regressions only showed a statistically signiﬁcant and lower dis-
utility (i.e., a higher TTO score) associated with individuals who
thought a lot about income and assumed it would decrease a
little. The authors conclude that this perverse result is almost
certainly attributable to the small number of respondents (7) in
this category. The most important conclusion of this study was
that survey respondents do not appear to have reduced their
TTO estimates to take account of a possible loss of income when
their health state implies an inability to work. Unfortunately,
information on background characteristics was not presented. It
would be particularly useful to have information on age and
occupation of the respondents to more incisively assess the
results obtained.
A study was performed by Myers and colleagues [33]. This
was the only study using the standard gamble (SG) method of
preference elicitation (for standard description of the SG method
see Drummond et al. [6]). They administered a paper SG exercise
to 181 undergraduate economics students in the United States.
The students were randomized into one of two groups. In group
1 no information was provided regarding income effects, while in
group 2 participants were simply informed that these effects
might occur. Students were presented with one of three health
states based on differing degrees of carpal tunnel syndrome (mild,
moderate, and severe). These states were anchored to the loss of
both hands rather than the conventional approach of anchoring
to death. The results showed that the overall mean QoL for the
group informed of the potential for income loss was lower than
subjects who were uninformed (P < 0.0001). For the mild state
the mean valuation for the informed group was 0.832 compared
with 0.903 for the uninformed group. For the severe state the
means are 0.626 for the informed group compared to 0.743 for
the uninformed group. Since differences were found between the
two groups the authors concluded that income losses are not
spontaneously included in the assessment of QoL weights.
However, at the individual level it seems quite plausible that
some may have spontaneously included these costs while others
may not. Moreover, the mentioning of potential income loss may
have increased the idea of severity of the projected health state
for the respondents. Background characteristics of the sample
were not presented, but since they were students they were pre-
sumably relatively young and had relatively low incomes. As
indicated earlier, how this may have affected answers is difﬁcult
to predict. Also, since the health states were anchored to the loss
of both hands rather than death, the comparability of the results
with the other studies is questionable.
Most recently, Davidson and Levin [36] asked 200 Swedish
students to value four EQ-5D states (11211, 11122, 21232, and
33321), through self-complete VAS and TTO exercises. The stu-
dents were randomly allocated to one of two groups: either the
income or nonincome group. The nonincome group received no
instruction regarding income while completing the valuations.
This group was asked a follow-up question: did you consider
your expected income when valuing the health states? Those that
stated that they had not included income effects were asked to
revalue the states, this time including expected income (ex post
inclusion). The income group received instructions to include
effects on expected income. This group was told to assume a
speciﬁc gross income per month at full health. Four different
income levels were used, but each student only had one income
level to consider.
The background characteristics of the study show that the
two groups did not differ signiﬁcantly in any variable. In the
non-income group 94% of respondents did not spontaneously
include income effects. When these were asked to revalue the
states including income effects, the TTO valuations were signiﬁ-
cantly lower for two of the four states, and the VAS valuations
were signiﬁcantly lower for three of the four states. In the income
group, 40% believed that thinking about their expected income
had affected their valuations of the health states. Students in the
income group were asked what percentage of their speciﬁed
income in full health they would expect to have in the health
states. The mean expected income percentages in the four states
were 73%, 82%, 47%, and 30%. Interestingly, although state
11122 was valued lower than state 11211, respondents felt that
states 11211 would have a larger effect on income. This suggests
that the usual activities dimension is perceived to have the great-
est effect on income. Comparison of the two groups showed that
the income group gave signiﬁcantly lower TTO valuations than
the nonincome group for only the mildest state. There were
signiﬁcantly lower VAS valuations among the income group for
the two most severe states. The main weakness of this study is
that the sample consists of students. The authors argue that
students were used because they generally have low, and similar,
incomes but with increasing expected incomes in the future.
However, we would argue that students do not have mortgages
or dependents and hence cannot relate to the ﬁnancial burden
and the stress associated with potentially not being able to meet
these demands. Given this, it is unsurprising that 94% of respon-
dents did not spontaneously consider income effects. The
approach of telling respondents to assume a ﬁxed given income
in full health further complicates the exercises and increases the
cognitive burden. Ultimately, the authors argue that productivity
costs should be included in the numerator rather than the
denominator of a cost-effectiveness analysis.
It is clear that the above studies draw inconsistent conclu-
sions, use various preference elicitation methods, samples and
study designs, and often suffer from important weaknesses.
Discussion and Research Agenda
While the Washington Panel recommendations may not have
received much support, they suggest that the line between costs
and effects in health economic evaluations has not been drawn
carefully enough and, therefore, current methods may lead to
double-counting when used in combination. Besides the empiri-
cal questions, a number of theoretical issues in this debate remain
unresolved. First, it is dubious whether income effects can be
considered a part of health effects, as suggested by the Washing-
ton Panel. Second, the use of income as an accurate proxy for
societal productivity costs is questionable. These considerations
may already lead to a preference for including productivity costs
on the cost-side of the C/E ratio, but does not take away the need
to address the empirical questions of whether, and how, people
take account of income losses when valuing health states.
The currently available empirical evidence on this issue
cannot be considered decisive or conclusive. There are some
inconsistencies between the conclusions of the existing studies.
On the topic of spontaneous inclusion of income effects, Meltzer
and colleagues [30] and Sendi and Brouwer [31] did ﬁnd signiﬁ-
cant differences between valuations of respondents including/
excluding income effects, while Krol and colleagues [32,35] and
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Richardson and colleagues [34] did not. The lower VAS scores
found by Sendi and Brouwer [31] among those who considered
income effects could be caused by the fact that the sample was
very small and consisted of health professionals. These are likely
to have a better understanding than the general public of the
effect a given health state will have on your ability to work and
hence your income. Moreover, as in other studies, the results may
also have been affected by differences in considering leisure time
between respondents. It seems important to better control for
differences in that respect. The studies on explicit ex ante instruc-
tion regarding inclusion or exclusion of income (but without
specifying the size of the effect) are also inconclusive. Krol and
colleagues [32,35] found no signiﬁcant differences. However,
Davidson and Levine [36] found that respondents instructed to
include income effects gave signiﬁcantly lower valuations than
those with no instructions in some cases. However, it seems that
explicitly mentioning (potential) income losses (but not telling
respondents what to do with this information) does affect HSV.
The results presented by Meltzer and colleagues [30] for back
pain (although not for blindness) seem to indicate this, as well as
the results of Myers and colleagues [33] for carpal tunnel syn-
drome. Such results may also indicate that explicit mentioning of
potential income losses may lead people to believe that the con-
dition is more severe than they ﬁrst imagined or that they empha-
size other aspects of work (such as role functioning) in their
subsequent valuation [24].
Empirically, the clearest conclusion so far is that, without
instructions, some people do include income effects while others
do not. The speciﬁc percentage of respondents that incorporate
these effects is less clear. Estimates range from 6% to 64% (when
income is not mentioned). This indicates that whether productiv-
ity costs are included in the numerator or the denominator, they
may be either under or over accounted for, depending on the effect
of inclusion of income effects on HSVs. If productivity costs are
included in the numerator and the inﬂuence of income effects on
HSVs is not negligible, then some double-counting will occur.
Alternatively, if productivity costs are to be included in the
denominator then productivity costs will be under accounted for,
since some people will not consider income effects in their valua-
tions (unless the inﬂuence on HSVs is unduly large). Furthermore,
if HSVs would indeed contain non-negligible income effects, this
poses a problem when decision makers in certain jurisdictions do
not wish to include productivity costs in health economic evalu-
ations in any way. The evidence so far, however, suggests that
possible double-counting, given the current way of deriving HSVs
(e.g., without specifying the size of income effects) seems to be
non-existent or, at least, negligible, given that most studies ﬁnd no
signiﬁcant differences in values between those that do and do not
consider income effects when the measure is silent. Although
explicit instruction similarly seems to make little difference to
valuations, for now the best solution may be to explicitly exclude
income effects and include productivity costs in the numerator.
The studies identiﬁed in this article have various weaknesses
and, while answering some questions, have also resulted in new
ones. Most studies have a limited sample size and four out of the
seven ask respondents to value speciﬁc health states (e.g., carpal
tunnel syndrome) rather than generic health states. This is an
important difference as respondents may be able to imagine more
easily the impact on their productivity due to speciﬁc diseases
than due to a general health proﬁle. In terms of relevance, it
would especially be useful to understand income effects within
generic instruments as these are now the most commonly used
metrics within economic evaluations and are also used to form
widely used population value sets. It is interesting to note that all
studies that have found signiﬁcant differences in values have
studied a speciﬁc condition. Neither of the studies using a generic
instrument, the EQ-5D, have found any notable differences. This
highlights the possibility that respondents may be able to relate
to a speciﬁc illness more easily and therefore may be more
capable and perhaps likely to envisage the broader consequences
of such an illness. It seems important to study the differences
between generic and disease-speciﬁc instruments further in future
research. The evidence seems to suggest that population value
sets derived using generic instruments such as the EQ-5D are not
noticeably inﬂuenced or “polluted” by income effects and there-
fore can be used alongside monetary valuation methods of pro-
ductivity costs, as well as in contexts where income effects are to
be excluded from the analysis completely.
Another noteworthy issue may be the experience people may
have (themselves or in others) with some health state. Not only
might this affect the valuation of that health state in general, but
it may also raise awareness of the broader consequences of illness
and therefore may affect the inclusion of such consequences.
Therefore, future research may study whether the inﬂuence of
knowledge of a speciﬁc health state or disease affects the likeli-
hood of considering income effects in the valuation of that health
state and, indeed, the valuation itself.
Five of the seven studies reviewed, with the notable exception
of the visually impaired patients in the Richardson and colleagues
[34] study (while the mode of administration is not clear in the
study byMeltzer and colleagues [30]), use self-complete question-
naires. Studies administering preference elicitation through inter-
views, despite being more time consuming and expensive, would
enable researchers to gain a greater understanding of the thought
processes at work when respondents are answering the questions
(perhaps through parallel qualitative probing).
There is undoubtedly a need for further empirical testing with
larger sample sizes to further address the question of what
respondents consider when answering preference elicitation
questions and how this inﬂuences their valuations. More inves-
tigation is needed into the role of income effects in generic
instruments such as the one already used, the EQ-5D, but also
others such as the SF-6D and the HUI. The HUI would be
particularly interesting as it already speciﬁcally rules out the
consideration of income effects. The effects of explicit instruction
also need to be investigated further. While it may be useful to
enhance the consistency of the inclusion or exclusion of certain
effects by explicit instruction, it may have unintended side effects
as well. Explicit instruction to ignore certain, previously unmen-
tioned, items from the valuation process may result in the oppo-
site if people ﬁnd it difﬁcult to explicitly exclude items. Moreover,
an explicit instruction to include certain aspects may lead them to
receive too much weight in the subsequent valuation procedure.
Therefore, if further evidence shows that explicit instruction
makes no difference, then the exclusion of productivity costs in
HSVs and thus from the numerator of the C/E ratio, might not
even need to be explicit. More research is needed in a wider
selection of countries since results are likely to be very sensitive to
the local social security system.
Some of the studies have not only looked at income effects but
at leisure effects related to ill health as well (since impaired health
may affect the utility derived from leisure time). It seems impor-
tant to continue to do so in future studies, not only to ﬁnd out
whether leisure is currently adequately valued in terms of QoL
[39] but in addition to disentangle leisure and income effects in
empirical studies.
Finally, improved understanding may be gained through sepa-
ration of the income and real health effects, e.g., by valuing just
health through a TTO exercise (with explicit exclusion of income
effects) and then valuing only income through a TTO exercise. It
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would be interesting to see if the relationship between income
and health proves to be additive or if there is some, more
complex, interaction between the two.
In conclusion, it is far from clear whether income effects are
in or out of HSVs and how this affects subsequent valuations.
New studies with an adequate sample size are needed, preferably
using representative samples of the general population in some
jurisdiction. The use of generic health states seems to be most
informative (since economic evaluations are now typically
informed by population value sets), such as EQ-5D states. Given
important differences between countries in terms of social secu-
rity systems etc, consideration should be given to the generaliz-
ability of results to other countries. Given the serious doubts
regarding the accuracy of valuing productivity losses through
QoL, monetary methods to include productivity costs seem pref-
erable. Whether this requires explicit instructions in order to
avoid double-counting needs further investigation. Until more
conclusive evidence is available in this area, economic evaluators
seeking to include productivity costs may wish to present results
from both the numerator and denominator methods as a sensi-
tivity analysis. They may also consider presenting results with
productivity costs excluded altogether. This would highlight the
inﬂuence on results, facilitate comparisons between jurisdictions
that do and do not take a societal perspective, and help avoid
double-counting. While it is too early to make a ﬁnal statement
on the question whether income is in or out of HSVs, the evi-
dence so far largely suggests that in terms of a reliable and
substantial impact on QoL it is out.
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